Parallels in the pathogenesis of SARS-CoV-2 and M. tuberculosis: a synergistic or antagonistic alliance?

Kesego Tapela; Charles Ochieng' Olwal; Osbourne Quaye

doi:10.2217/fmb-2020-0179

Parallels in the pathogenesis of SARS-CoV-2 and M. tuberculosis: a synergistic or antagonistic alliance?

Future Microbiol. 2020 Dec:15:1691-1695. doi: 10.2217/fmb-2020-0179. Epub 2021 Jan 6.

Authors

Kesego Tapela^{1

2}, Charles Ochieng' Olwal^{1

2}, Osbourne Quaye^{1

2}

Affiliations

¹ West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana.
² Department of Biochemistry, Cell & Molecular Biology, College of Basic & Applied Sciences, University of Ghana, Accra, Ghana.

No abstract available

Keywords: BCG vaccine; COVID-19; Mycobacterium tuberculosis; SARS-CoV-2; angiotensin-converting enzyme 2 (ACE2) receptor; coronavirus; cytokine storm; lymphocytopenia; pathogenesis of SARS-CoV-2; tuberculosis.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

BCG Vaccine / pharmacology
COVID-19 / immunology
COVID-19 / microbiology*
COVID-19 / parasitology
COVID-19 / virology
Coinfection / microbiology*
Coinfection / virology
Cytokines / immunology
Humans
Immunity / immunology
Mycobacterium tuberculosis / pathogenicity*
SARS-CoV-2 / pathogenicity*
Tuberculosis / immunology
Tuberculosis / microbiology*
Tuberculosis / virology

Substances

BCG Vaccine
Cytokines